GSA Capital Partners’s BioNTech BNTX Stock Holding History

GSA Capital Partners’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$331K	Sell	3,560 -739	-17%	-$69.5K	0.02%	1242
2026 Q1	$382K	Buy	+4,299	New	+$442K	0.02%	1094
2024 Q4	–	Sell	-3,138	Closed	-$373K	–	1621
2024 Q3	$373K	Buy	+3,138	New	+$288K	0.03%	1116
2024 Q2	–	Sell	-3,625	Closed	-$334K	–	1639
2024 Q1	$334K	Buy	+3,625	New	+$348K	0.03%	1146
2023 Q3	–	Sell	-5,510	Closed	-$595K	–	1503
2023 Q2	$595K	Buy	5,510 +441	+9%	+$49.6K	0.06%	636
2023 Q1	$631K	Buy	5,069 +655	+15%	+$89.9K	0.06%	570
2022 Q4	$663K	Buy	+4,414	New	+$679K	0.08%	426
2022 Q3	–	Sell	-3,743	Closed	-$558K	–	1529
2022 Q2	$558K	Buy	+3,743	New	+$572K	0.08%	429
2022 Q1	–	Sell	-1,227	Closed	-$316K	–	1423
2021 Q4	$316K	Buy	+1,227	New	+$336K	0.04%	891
2021 Q3	–	Sell	-1,647	Closed	-$369K	–	1439
2021 Q2	$369K	Buy	+1,647	New	+$311K	0.04%	812

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

GSA Capital Partners's BNTX Position: Q2 2026 in Review

GSA Capital Partners reduced its BioNTech (BNTX) stake by 17% in Q2 2026, selling an estimated $69.5K and leaving 3,560 shares worth $331K. The position accounts for 0.02% of the portfolio, ranked #1242.

GSA Capital Partners first reported a position in BNTX in Q2 2021 and has held it in 10 quarters since. The position peaked at $663K in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

GSA Capital Partners held 3,560 shares of BioNTech worth $331K as of Q2 2026.
GSA Capital Partners sold 739 BioNTech shares in Q2 2026, an estimated $69.5K.
BioNTech made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1242 holding.
GSA Capital Partners first reported a position in BioNTech in Q2 2021 and has held it in 10 quarters since.
GSA Capital Partners's BioNTech position peaked at $663K in Q4 2022.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.